Actinogen Medical Financials

ACW Stock   0.04  0  2.78%   
We suggest to use Actinogen Medical fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if Actinogen Medical is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We are able to interpolate and break down twenty-seven available fundamental indicators for Actinogen Medical, which can be compared to its peers. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Actinogen Medical to be traded at 0.0336 in 90 days. Key indicators impacting Actinogen Medical's financial strength include:
Operating Margin
(0.18)
Profit Margin
(1.31)
EPS Estimate Current Year
(0)
Return On Equity
(0.79)
  
Understanding current and past Actinogen Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Actinogen Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Actinogen Medical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Actinogen Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Actinogen Medical. Check Actinogen Medical's Beneish M Score to see the likelihood of Actinogen Medical's management manipulating its earnings.

Actinogen Medical Stock Summary

Actinogen Medical competes with FireFly Metals, Aurelia Metals, Aussie Broadband, and Retail Food. Actinogen Medical is entity of Australia. It is traded as Stock on AU exchange.
Foreign Associate
  USA
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentAustralia Stock View All
ExchangeAustralian Securities Exchange
ISINAU000000ACW3
Business Address109 Pitt Street,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websiteactinogen.com.au
Phone61 2 8964 7401
You should never invest in Actinogen Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Actinogen Stock, because this is throwing your money away. Analyzing the key information contained in Actinogen Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Actinogen Medical Key Financial Ratios

Actinogen Medical's financial ratios allow both analysts and investors to convert raw data from Actinogen Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Actinogen Medical over time and compare it to other companies across industries.

Actinogen Medical Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets18.4M23.3M15.2M21.3M24.5M25.7M
Other Current Liab291.7K502.5K613.2K699.1K803.9K844.1K
Cash13.4M16.4M8.5M9.5M10.9M11.4M
Net Receivables1.5M3.9M3.9M9.4M10.8M11.4M
Total Liab920.3K1.6M1.8M1.6M1.9M2.0M
Common Stock60.1M76.9M78.7M100.0M115.0M120.8M
Other Current Assets90.0K104.6K344.5K108.8K125.2K134.7K
Net Debt(13.2M)(16.2M)(8.4M)(9.1M)(8.2M)(8.6M)
Retained Earnings(48.4M)(57.9M)(68.7M)(81.7M)(73.6M)(69.9M)
Accounts Payable392.2K898.7K1.1M597.2K686.8K353.5K
Total Current Assets15.1M20.4M12.7M18.9M21.7M22.8M
Intangible Assets3.0M2.7M2.4M2.1M2.4M2.7M
Net Tangible Assets7.5M14.4M19.0M11.0M12.6M10.9M
Short Term Debt71.2K78.3K86.9K60.7K54.6K51.9K
Net Invested Capital17.5M21.7M13.4M19.7M22.7M17.3M
Cash And Equivalents3.6M7.1M12.1M7.2M8.3M7.8M
Net Working Capital14.3M18.9M10.9M17.5M20.1M13.5M
Capital Stock60.1M76.9M78.7M100.0M115.0M75.5M

Actinogen Medical Key Income Statement Accounts

202020212022202320242025 (projected)
Interest Expense22.3K18.5K16.6K24.3K27.9K29.3K
Total Revenue2.0M3.6M4.9M9.9M11.4M12.0M
Gross Profit1.6M3.2M4.5M9.9M11.4M12.0M
Operating Income(5.9M)(13.2M)(15.9M)(12.8M)(11.6M)(11.0M)
Ebit(5.7M)(13.1M)(15.6M)(13.3M)(12.0M)(11.4M)
Ebitda(5.3M)(12.7M)(15.2M)(12.9M)(11.6M)(11.0M)
Cost Of Revenue386.7K400.7K405.6K416.8K479.4K334.9K
Income Before Tax(5.8M)(13.1M)(15.6M)(23.0M)(20.7M)(19.6M)
Net Income(3.9M)(9.5M)(10.8M)(13.0M)(11.7M)(11.2M)
Income Tax Expense(1.8M)(3.6M)(4.9M)(9.9M)(8.9M)(8.5M)
Research Development2.4M8.2M8.9M15.5M17.9M18.8M
Interest Income27.1K41.1K366.7K291.0K334.7K351.4K
Net Interest Income4.8K22.6K350.1K266.7K306.7K322.1K

Actinogen Medical Key Cash Accounts

202020212022202320242025 (projected)
Capital Expenditures6.2K2.9K36.6K8.2K7.3K14.4K
End Period Cash Flow13.4M16.4M8.5M9.5M10.9M5.5M
Change In Cash8.4M2.9M(7.9M)990.7K891.6K936.2K
Free Cash Flow(1.7M)(9.5M)(8.7M)(17.0M)(15.3M)(14.5M)
Depreciation386.7K400.7K405.6K416.8K479.4K244.7K
Other Non Cash Items1.8M3.8M2.3M912.1K1.0M1.1M
Net Income(3.9M)(9.5M)(10.8M)(13.0M)(11.7M)(11.2M)
Investments(6.2K)(2.9K)(36.6K)(8.2K)(9.4K)(9.9K)
Change To Netincome194.5K289.3K1.3M1.5M1.7M1.8M
Change To Inventory(100.4K)(26.1K)(717.3K)(313.5K)(282.1K)(296.2K)

Actinogen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Actinogen Medical's current stock value. Our valuation model uses many indicators to compare Actinogen Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Actinogen Medical competition to find correlations between indicators driving Actinogen Medical's intrinsic value. More Info.
Actinogen Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Actinogen Medical's earnings, one of the primary drivers of an investment's value.

Actinogen Medical Systematic Risk

Actinogen Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Actinogen Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-one with a total number of output elements of fourty. The Beta measures systematic risk based on how returns on Actinogen Medical correlated with the market. If Beta is less than 0 Actinogen Medical generally moves in the opposite direction as compared to the market. If Actinogen Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Actinogen Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Actinogen Medical is generally in the same direction as the market. If Beta > 1 Actinogen Medical moves generally in the same direction as, but more than the movement of the benchmark.

Actinogen Medical Total Assets Over Time

Actinogen Medical Thematic Clasifications

Actinogen Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
DrugsView
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas

Actinogen Medical February 18, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Actinogen Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Actinogen Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Actinogen Medical based on widely used predictive technical indicators. In general, we focus on analyzing Actinogen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Actinogen Medical's daily price indicators and compare them against related drivers.

Additional Tools for Actinogen Stock Analysis

When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.